Key result
Women with ACS face worse outcomes than men, though advanced therapies are narrowing the gap.
Why the study?
Are there gender differences in outcomes in patients with acute coronary syndrome in the current era?
Are there gender differences in outcomes in patients with acute coronary syndrome in the current era?
This review highlights that while women historically have poorer outcomes after acute coronary syndrome, the gap is narrowing with modern interventional and pharmacological therapies.
Warrants heightened vigilance for women with ACS; leaves open mechanisms and optimal interventions for dedicated trials.
Coronary heart disease is the most common cause of death worldwide. In the United Kingdom in 2010, over 80,000 deaths were attributed to coronary heart disease, and one in 10 female deaths were due to coronary heart disease. Acute coronary syndrome, a subset of coronary heart disease, was responsible for 175,000 inpatient admissions in the United Kingdom in 2012. While men have traditionally been considered to be at higher risk of acute coronary syndrome, various studies have demonstrated that women often suffer from poorer outcomes following an adverse cardiovascular event. This gap is gradually narrowing with the introduction of advanced interventional strategies and pharmacotherapy. However, a better understanding of these differences is of crucial importance for the improvement of the pharmacological and interventional management of acute coronary syndrome and for the development of possible new gender-specific diagnostic and therapeutic options. The goals of this review are to evaluate gender differences in outcomes in patients with acute coronary syndrome in the current era and identify potential mechanisms behind these differences in outcomes following percutaneous coronary intervention.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2015) conducted a review in Acute coronary syndrome. Women with acute coronary syndrome often suffer from poorer outcomes following an adverse cardiovascular event compared to men, though this gap is gradually narrowing with advanced therapies.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: